Kestra Medical Technologies, Ltd.
KMTSNASDAQHealthcareMedical - Instruments & Supplies
Previous close
$26.99
−$0.27 · -0.99%
KMTS company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
62
Undervalued
Momentum
64
Gaining
Sentiment
41
Mixed
Risk resilience
55
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteKestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Brian Webster
- Listed since
- Mar 6, 2025
- Employees
- 443
Market position
Day range
Current $26.99
52-week range
Current $26.99
- Open
- $27.41
- Previous close
- $27.26
- Volume
- 510.81K
- 1.5× average
- Average volume
- 340.38K
- Average daily volume
- Market cap
- 1.58B USD
- Beta
- 0.58
- Market reference 1
- 50-day average
- $24.4468
- +10.40% above average
- 200-day average
- $23.5955
- +14.39% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.16B USD
- P/E (TTM)
- -11.15×
- P/B (TTM)
- 6.07×
- P/S (TTM)
- 16.63×
- EV / EBITDA
- -7.71×
- Earnings yield
- -10.88%
- Free cash flow yield
- -9.64%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 51.37%
- Operating margin
- -141.64%
- Net margin
- -138.36%
- Return on equity
- -50.69%
- Return on assets
- -36.72%
- Return on invested capital
- -43.73%
Financial health
- Debt / equity
- 0.18×
- Current ratio
- 4.41×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 95.13M USD | 59.82M USD | 27.81M USD | 7.63M USD |
| Cost of goods sold | 46.26M USD | 35.61M USD | 27.45M USD | 18.28M USD |
| Gross profit | 48.86M USD | 24.21M USD | 362K USD | −10.65M USD |
| Research and development | 19.48M USD | 15.65M USD | 15.49M USD | 15.76M USD |
| Selling, general, and administrative | 164.12M USD | 114.94M USD | 69.94M USD | 54.01M USD |
| Operating expenses | 183.6M USD | 130.59M USD | 85.43M USD | 69.77M USD |
| Interest income | 8.35M USD | 3.2M USD | — | — |
| Interest expense | 7.55M USD | 7.73M USD | 6.23M USD | 5.63M USD |
| Depreciation and amortization | −4.4M USD | 7.97M USD | 11.56M USD | 4.86M USD |
| Operating income | −134.74M USD | −106.38M USD | −85.06M USD | −80.42M USD |
| Net income | −131.61M USD | −113.81M USD | −94.12M USD | −84.24M USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest fiscal-year EPS
- -2.43
- FY2026
- Latest fiscal-year revenue
- 95.13M USD
- FY2026 · +59.04% year over year
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
4 ratingsLimited analyst sample: 4 ratings. Interpret the distribution with caution.
KMTS news
KMTS peers
ETFs holding KMTS
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI21.17M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM18.6M0.02%81.62B USD0.19%$299.96+0.77%
iShares Russell 2000 Growth ETFIWO6.85M0.05%15.16B USD0.24%$387.37+1.24%
First Trust Small Cap Growth AlphaDEX FundFYC5.89M0.42%1.42B USD0.70%$122+0.71%
Vanguard Extended Market ETFVXF5.09M0.01%93.7B USD0.05%$245.53+0.82%
Vanguard Russell 2000 ETFVTWO3.43M0.02%17.4B USD0.06%$121.25+0.74%
T. Rowe Price Small-Mid Cap ETFTMSL3.36M0.11%3B USD0.55%$43.59+0.60%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP3.12M0.12%2.71B USD0.20%$69.24+0.92%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 21.17M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 18.6M
- Weight
- 0.02%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
iShares Russell 2000 Growth ETFIWO- Market value
- 6.85M
- Weight
- 0.05%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
First Trust Small Cap Growth AlphaDEX FundFYC- Market value
- 5.89M
- Weight
- 0.42%
- AUM
- 1.42B USD
- Expense ratio
- 0.70%
- Price / 1D
- $122+0.71%
Vanguard Extended Market ETFVXF- Market value
- 5.09M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Vanguard Russell 2000 ETFVTWO- Market value
- 3.43M
- Weight
- 0.02%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
T. Rowe Price Small-Mid Cap ETFTMSL- Market value
- 3.36M
- Weight
- 0.11%
- AUM
- 3B USD
- Expense ratio
- 0.55%
- Price / 1D
- $43.59+0.60%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP- Market value
- 3.12M
- Weight
- 0.12%
- AUM
- 2.71B USD
- Expense ratio
- 0.20%
- Price / 1D
- $69.24+0.92%
Continue in GoAI
Research KMTSresearch.disclaimer